Workday Lights the SaaS Fuse

Welcome to LazyListen. This is The Daily Rip for today. Markets closed mixed Thursday as chip equipment giant Applied Materials beat earnings and raised guidance, but shares slipped after hours.

Meanwhile, software stocks lit up on news that private equity firm Silver Lake is in talks to acquire Workday, sparking a broad rally in subscription software names. Let’s break down what moved markets and why it matters. -related semiconductor tools.

Revenue rose nearly twenty five percent to over nine billion dollars, and adjusted earnings per share came in at three dollars and fifty cents, beating estimates. The company also raised its fourth-quarter revenue and earnings guidance above expectations, signaling continued strength in chip equipment spending through 2027. Despite this, shares fell about four percent after hours, reflecting investor caution after the stock had already more than doubled this year and trades at a premium valuation compared to peers like Nvidia and Alphabet.

The takeaway here is that while fundamentals remain solid, the market is looking for even more upside to justify the rich price. Turning to software, Silver Lake’s reported interest in acquiring Workday ignited a powerful rally across the sector. Workday’s shares surged nearly eighteen percent, closing above two hundred six dollars after hitting a thirty percent intraday gain, the biggest one-day move in its history.

I. disruption narratives, including Figma, UiPath, Adobe, and Salesforce, all posting gains between four and eleven percent. I.

might reshape or even hollow out traditional seat-based licensing models. The market is now watching to see if this marks the start of a lasting re-rating for software stocks or just a one-day takeover speculation spike. Workday’s upcoming earnings report on August 27 will be a key test, as will any firm deal terms emerging from these talks.

-driven growth and monetization against the risk that the buyout interest may not materialize. In other movers, a few notable sector themes stood out. In tech services, TSS, a provider focused on procurement and systems integration, saw its shares drop twenty-seven percent after reporting a twenty percent revenue decline.

The fall was driven by a sharp drop in lower-margin procurement sales, overshadowing growth in higher-margin systems integration. This raised questions about how dependent the business remains on a single major customer and whether the market is correctly pricing the company’s evolving business mix. On the innovation fund front, Fundrise Innovation Fund jumped twenty-one percent ahead of a scheduled unlocking of previously restricted shares.

The fund holds stakes in high-profile names like SpaceX and Anthropic, and the early release of shares has traders debating whether the fund can maintain its premium valuation amid increased supply. In biotech, Candel gained seven percent as investors focused on its upcoming regulatory milestone—a biologics license application for a prostate cancer therapy expected in the fourth quarter. The move reflects optimism that manufacturing readiness has reduced filing risks, though some caution remains about whether partnership or buyout hopes are premature ahead of FDA review.

m. m. , Outlook Therapeutics, and NRX Pharmaceuticals, among others.

After the close, SUNation Energy, Citius Pharmaceuticals, New Era Energy, and several others will report. -driven capital spending, with Applied Materials confirming strong demand but facing valuation scrutiny. I.

disruption. Meanwhile, select tech services, innovation funds, and biotech names are navigating their own catalysts and risks. Tomorrow’s data and earnings will provide fresh clues on consumer demand and sector momentum as markets digest these developments.

Thanks for listening. Catch you next time on LazyListen.